Skip to main navigation Skip to search Skip to main content

Synthesis, cytotoxic study and docking based multidrug resistance modulator potential analysis of 2-(9-oxoacridin-10(9H)-yl)-N-phenyl acetamides

  • Rajesh Kumar
  • , Maninder Kaur
  • , Malkeet Singh Bahia
  • , Om Silakari
  • Pharmaceutical Chemistry Division, Shivalik College of Pharmacy
  • Punjabi University

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Abstract

The present study describes the synthesis of fifteen 2-(9-oxoacridin-10(9H) -yl)-N-phenyl acetamide derivatives (13a-o) through condensation of 2-chloro-N-phenyl acetamides (12a-o) with acridone molecule (10). All the synthesized compounds were screened for their anti-cancer activity against three diverse cell lines including breast (MCF-7), cervical (HeLa) and lung adenocarcinoma (A-549) employing standard MTT assay. Among synthesized molecules, 13k and 13l showed good cytotoxicity activity against considered three cancer cell lines. Additionally, in silico studies of multidrug resistance modulator (MDR) effects of these compounds was performed by docking simulation in the ATP binding site of P-gp. The results of docking simulation displayed important interactions of these molecules in the active site of this protein and predicted their MDR modulator behavior.

Original languageEnglish
Pages (from-to)83-91
Number of pages9
JournalEuropean Journal of Medicinal Chemistry
Volume80
DOIs
StatePublished - 10 Jun 2014
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Acridone derivatives
  • Cytotoxicity
  • Docking analysis
  • MTT assay
  • Multidrug resistance

Fingerprint

Dive into the research topics of 'Synthesis, cytotoxic study and docking based multidrug resistance modulator potential analysis of 2-(9-oxoacridin-10(9H)-yl)-N-phenyl acetamides'. Together they form a unique fingerprint.

Cite this